Microvast (MVST) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Oct, 2026Executive summary
Virtual annual meeting set for Nov. 30, 2026, at 9:00 a.m. Central Time; Oct. 6, 2026 is the record date, with 385,921,813 common shares outstanding.
Stockholders will vote on a Class II director, Deloitte’s FY2026 appointment, executive compensation and the frequency of future say-on-pay votes.
Voting matters and shareholder proposals
Arthur Wong is nominated for a three-year Class II term expiring at the 2029 annual meeting; the Board recommends a FOR vote.
The Board recommends FOR ratification of Deloitte for FY2026; the Audit Committee may reconsider its appointment if stockholders do not ratify it.
The advisory say-on-pay vote is non-binding; the Compensation Committee and Board will consider results in future compensation decisions.
The Board recommends annual say-on-pay votes; the advisory frequency choices are every one, two or three years, and results will inform future decisions.
Proposals for inclusion in the 2027 proxy are due June 11, 2027; other proposals and director nominations require notice between Aug. 2 and Sept. 1, 2027.
Board of directors and corporate governance
The Board has five members in three staggered classes; Yixin Pan, Wei Ying and Arthur Wong are independent. Yang Wu combines the Chair and CEO roles.
During FY2025, the Board met 12 times; the Audit Committee met 20 times, while the Compensation and Nominating and Corporate Governance committees each met five times.
The Compensation Committee is independent and uses FW Cook as an independent adviser; the Board and each committee conduct annual performance assessments.
The Board evaluates its leadership structure with flexibility to separate the Chair and CEO roles; independent directors meet in executive session.
Latest events from Microvast
- Proxy card sets four voting matters, with the Board favoring annual say-on-pay votes.MVST
Proxy filing - Board recommends annual say-on-pay votes and approval of the director, auditor, and compensation proposals.MVST
Proxy filing - Revenue fell 4.5% and gross margin dropped to 29.5% as capacity expansions progressed.MVST
Q2 2026 - Revenue dropped 48% year-over-year, but margin resilience and fair value gains supported results.MVST
Q1 2026 - Record revenue and positive adjusted EBITDA, despite margin hit from inventory impairment.MVST
Q4 2025 - Offering up to $250M in securities to support growth in U.S. battery technology and production.MVST
Registration Filing - Q3 profit and 27% revenue growth driven by EMEA, but liquidity and expansion risks persist.MVST
Q3 2024 - Q2 revenue up 12% to $83.7M, EMEA surged, but net loss widened on impairment and liquidity risks.MVST
Q2 2024 - Record revenue, margin gains, and $401M backlog support strong 2025 growth outlook.MVST
Q4 2024